Cargando…
2-[4-(2-Chlorobenzyl)-3-methyl-6-oxo-1,6-dihydropyridazin-1-yl]-N-(4-fluorophenyl)acetamide
The conformation of the title molecule, C(20)H(17)ClFN(3)O(2), is partly determined by an intramolecular C—H⋯O hydrogen bond, which leads to a dihedral angle of 14.7 (4)° between the fluorobenzene ring and the acetamide group. The 2-chlorobenzyl group is rotationally disordered over two orientat...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626847/ https://www.ncbi.nlm.nih.gov/pubmed/37936589 http://dx.doi.org/10.1107/S241431462300901X |
_version_ | 1785131425981267968 |
---|---|
author | Assila, Hamza Ameziane El Hassani, Issam El Moutaouakil Ala Allah, Abderrazzak Alsubari, Abdulsalam Mague, Joel T Ramli, Youssef Ansar, MHammed |
author_facet | Assila, Hamza Ameziane El Hassani, Issam El Moutaouakil Ala Allah, Abderrazzak Alsubari, Abdulsalam Mague, Joel T Ramli, Youssef Ansar, MHammed |
author_sort | Assila, Hamza |
collection | PubMed |
description | The conformation of the title molecule, C(20)H(17)ClFN(3)O(2), is partly determined by an intramolecular C—H⋯O hydrogen bond, which leads to a dihedral angle of 14.7 (4)° between the fluorobenzene ring and the acetamide group. The 2-chlorobenzyl group is rotationally disordered over two orientations in a 0.656 (2): 0.344 (2) ratio. In the crystal, a layered structure is formed by N—H⋯O, C—H⋯O and C—H⋯F hydrogen bonds plus slipped π–π stacking interactions. [Image: see text] |
format | Online Article Text |
id | pubmed-10626847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | International Union of Crystallography |
record_format | MEDLINE/PubMed |
spelling | pubmed-106268472023-11-07 2-[4-(2-Chlorobenzyl)-3-methyl-6-oxo-1,6-dihydropyridazin-1-yl]-N-(4-fluorophenyl)acetamide Assila, Hamza Ameziane El Hassani, Issam El Moutaouakil Ala Allah, Abderrazzak Alsubari, Abdulsalam Mague, Joel T Ramli, Youssef Ansar, MHammed IUCrdata Data Reports The conformation of the title molecule, C(20)H(17)ClFN(3)O(2), is partly determined by an intramolecular C—H⋯O hydrogen bond, which leads to a dihedral angle of 14.7 (4)° between the fluorobenzene ring and the acetamide group. The 2-chlorobenzyl group is rotationally disordered over two orientations in a 0.656 (2): 0.344 (2) ratio. In the crystal, a layered structure is formed by N—H⋯O, C—H⋯O and C—H⋯F hydrogen bonds plus slipped π–π stacking interactions. [Image: see text] International Union of Crystallography 2023-10-19 /pmc/articles/PMC10626847/ /pubmed/37936589 http://dx.doi.org/10.1107/S241431462300901X Text en © Assila et al. 2023 https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited. |
spellingShingle | Data Reports Assila, Hamza Ameziane El Hassani, Issam El Moutaouakil Ala Allah, Abderrazzak Alsubari, Abdulsalam Mague, Joel T Ramli, Youssef Ansar, MHammed 2-[4-(2-Chlorobenzyl)-3-methyl-6-oxo-1,6-dihydropyridazin-1-yl]-N-(4-fluorophenyl)acetamide |
title | 2-[4-(2-Chlorobenzyl)-3-methyl-6-oxo-1,6-dihydropyridazin-1-yl]-N-(4-fluorophenyl)acetamide |
title_full | 2-[4-(2-Chlorobenzyl)-3-methyl-6-oxo-1,6-dihydropyridazin-1-yl]-N-(4-fluorophenyl)acetamide |
title_fullStr | 2-[4-(2-Chlorobenzyl)-3-methyl-6-oxo-1,6-dihydropyridazin-1-yl]-N-(4-fluorophenyl)acetamide |
title_full_unstemmed | 2-[4-(2-Chlorobenzyl)-3-methyl-6-oxo-1,6-dihydropyridazin-1-yl]-N-(4-fluorophenyl)acetamide |
title_short | 2-[4-(2-Chlorobenzyl)-3-methyl-6-oxo-1,6-dihydropyridazin-1-yl]-N-(4-fluorophenyl)acetamide |
title_sort | 2-[4-(2-chlorobenzyl)-3-methyl-6-oxo-1,6-dihydropyridazin-1-yl]-n-(4-fluorophenyl)acetamide |
topic | Data Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626847/ https://www.ncbi.nlm.nih.gov/pubmed/37936589 http://dx.doi.org/10.1107/S241431462300901X |
work_keys_str_mv | AT assilahamza 242chlorobenzyl3methyl6oxo16dihydropyridazin1yln4fluorophenylacetamide AT amezianeelhassaniissam 242chlorobenzyl3methyl6oxo16dihydropyridazin1yln4fluorophenylacetamide AT elmoutaouakilalaallahabderrazzak 242chlorobenzyl3methyl6oxo16dihydropyridazin1yln4fluorophenylacetamide AT alsubariabdulsalam 242chlorobenzyl3methyl6oxo16dihydropyridazin1yln4fluorophenylacetamide AT maguejoelt 242chlorobenzyl3methyl6oxo16dihydropyridazin1yln4fluorophenylacetamide AT ramliyoussef 242chlorobenzyl3methyl6oxo16dihydropyridazin1yln4fluorophenylacetamide AT ansarmhammed 242chlorobenzyl3methyl6oxo16dihydropyridazin1yln4fluorophenylacetamide |